Achillion Pharmaceuticals
(NASDAQ: ACHN)
8.13
+0.12
+1.50%
+0.12
+1.50%
MORE ON ACHN
View:
The following corporate insiders or major shareholders have recently filed transaction reports with the SEC. Click a name to see transaction details. To see a different set of transactions, select All Transactions, Most Recent Transactions, or Planned Sales from the list.
RECENT INSIDER TRANSACTIONS ACTIVITY: ACHILLION PHARMACEUTICALS
| DATE | NAME | TRANSACTION | NUM SHARES | PRICE(S) | VALUE |
|---|---|---|---|---|---|
| 06/07/13 | Mr. Gary E. Frashier | Sold | 5,000 | 8.37 | 41,850 |
| 06/07/13 | Mr. Gary E. Frashier | NA | 10,000 | 1.33 | 13,300 |
| 06/03/13 | Dr. Jason S. Fisherman,M.D. | Purchase | 10,000 | 7.87 | 78,700 |
| 06/03/13 | Dr. Dennis Liotta | Purchase | 20,000 | 7.91 | 158,106 |
| 05/28/13 | Milind S. Deshpande,PhD | Grant | 600,000 | NA | NA |
| 05/28/13 | David Apelian | Grant | 200,000 | NA | NA |
| 01/18/13 | Schoemaker Kathleen K | NA | 1.07 Mil | NA | NA |
| 01/18/13 | Nicole Vitullo | NA | 1.07 Mil | NA | NA |
| 01/18/13 | Dr. Brian K. Halak,PhD | NA | 1.07 Mil | NA | NA |
| 01/18/13 | Dr. Jesse I. Treu,PhD | NA | 1.07 Mil | NA | NA |
| 01/18/13 | James C. Blair,PhD | NA | 1.07 Mil | NA | NA |
| 01/18/13 | Brian H. Dovey | NA | 1.07 Mil | NA | NA |
| 01/02/13 | Gautam Shah,PhD | NA | 53,930 | 1.57 | 84,713.62 |
| 01/02/13 | Gautam Shah,PhD | Sold | 26,965 | 8.40 | 226,613.86 |
| 12/31/12 | Gautam Shah,PhD | NA | 176,336 | 1.38 | 242,777.82 |
| 12/31/12 | Gautam Shah,PhD | Sold | 88,168 | 8.01 | 706,093.43 |
| 12/18/12 | Mr. David I. Scheer | Grant | 20,000 | NA | NA |
| 12/18/12 | Joseph Truitt | Grant | 145,000 | NA | NA |
| 12/18/12 | Dr. Dennis Liotta | Grant | 20,000 | NA | NA |
- Financial data in USD
Insider filings are updated daily and are based on forms filed monthly with the SEC.
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.